Tempest Therapeutics Aktie (A3CSM8

Was macht Tempest Therapeutics?

Unternehmensprofil

Tempest Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development and discovery of small molecule drugs for the treatment of cancer. The company was founded in 2011 and is headquartered in Brisbane, CA.

Chart der Tempest Therapeutics Aktie

Charttool öffnen

Aktuelle Nachrichten zu Tempest Therapeutics

Weitere Nachrichten

Das berichten andere über Tempest Therapeutics

Tempest Therapeutics stock surges after H.C. Wainwright upgrade By Investing.com

Tempest Therapeutics stock surges after H.C. Wainwright upgrade

Tempest Therapeutics receives Nasdaq notice for annual meeting compliance By Investing.com

Tempest Therapeutics receives Nasdaq notice for annual meeting compliance

Tempest Therapeutics closes $4.25 million registered direct offering By Investing.com

Tempest Therapeutics closes $4.25 million registered direct offering

Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027

BRISBANE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- In a transaction designed to both expand its pipeline and extend its runway, Tempest Therapeutics, Inc. (Nasdaq: TPST)...